1[1]Losonsky G A,otloff K L,alker R I,t al. B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals[J]. Vaccine,003,1(5-6): 562-565.
2[2]Kotloff K L,ztein M B,asserman S S,t al. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection[J]. Infect Immun,001,9(6): 3581-3590.
3[3]Ruggiero P,eppoloni S,appuoli R,t al. The quest for a vaccine against Helicobacter pylori: how to move from mouse to man[J]? Microbes Infect,003,(8): 749-756.
4[4]Dilts D A,iesenfeld Orn I,ulginiti J P,t al. Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines;effect of formulation on safety and immunogenicity[J]. Vaccine,000,18(15): 1473-1484.
5[5]Del-Giudice G. Towards the development of vaccines against Helicobacter pylori: status and issues[J]. Curr Opin Investig Drugs,001,2(1): 40-44.
6[6]Sutton P,ilson J,osaka T,t al. Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies[J]. Immunol Cell Biol,000,8(1): 28-30.
7[7]Peppoloni S,ancianti S,olpini G,t al. Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement[J]. Eur J Immunol,002,2(10): 2721-2725.
8[8]Sutton P. Progress in vaccination against Helicobacter pylori[J]. Vaccine,001,9(17-19): 2286-2290.
9[9]Maeda K,amashiro T,inoura T,t al. Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection[J]. Microbiol Immunol,002,6(9): 613-620.
10[10]Garhart C A,einzel F P,zinn S J,t al. Vaccine-induced reduction of Helicobacter pylori colonization in mice is interleukin-12 dependent but gamma interferon and inducible nitric oxide synthase independent[J]. Infect Immun,003,1(2): 910-921.
8Pridgeon JW, Klesius PH. Development and efficacy of novobiocin and rifampicin-resistant Aeromonas hydrophila as novelvaccines in channel catfish and Nile tilapia[J]. Vaccine,2011,29(45): 7896-7904.
9Wu L, Jiang YN,Tang Q,et al. Development of an Aeromonas hydrophila recombinant extracellular protease vaccine[J]. MicrobPathog, 20*2, 53(5-6): 183-188.
10Vivas J,Carracedo B, Riafto J, et al. Behavior of an Aeromonas hydrophila aroA live vaccine in water microcosms[J]. ApplEnviron Microbiol, 2004, 70(5): 2702-2708.
